1. Ogilvie,G., Sauvageau, C., Dionne, M., McNeil, S., Krajden,M., Money, D. & Dobson, S. (2017). Immunogenicity of 2 vs 3 Doses of the Quadrivalent Human Papillomavirus Vaccine in Girls Aged 9 to 13 Years After 60 Months, JAMA, April 25, 2017; 317; 16;16817.
  2. Meites E, Kempe A, Markowitz LE. Use of a 2-Dose Schedule for Human Papillomavirus Vaccination — Updated Recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 2016;65:1405–1408. DOI:
  3. Tools for providers to talk with parents about HPV Immunization: